Janux Therapeutics (JANX) IPO Doubles on Open

Today's IPO for Janux Therapeutics (NASDAQ: JANX) opened for trading at $34 after pricing 11,400,000 shares of its common stock at $17.

BofA Securities, Cowen and Evercore ISI are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.

Janux Therapeutics is a biopharmaceutical company developing novel T cell engager immunotherapies.

You May Also Be Interested In

• Shein targets $26-27 billion valuation in Hong Kong IPO - report
• Alopexx (ALPX) files for 3M share IPO at $10-$12/sh
• Harvard discloses $2.2B SpaceX stake, over half its U.S. equity portfolio